SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-19-002458
Filing Date
2019-04-17
Accepted
2019-04-17 10:30:14
Documents
4
Period of Report
2019-05-29
Effectiveness Date
2019-04-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a_041719.htm DEF 14A 852902
2 GRAPHIC logo.jpg GRAPHIC 5734
3 GRAPHIC proxy1.jpg GRAPHIC 72598
4 GRAPHIC proxy2.jpg GRAPHIC 47186
  Complete submission text file 0001171843-19-002458.txt   1027185
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 19752416
SIC: 2836 Biological Products, (No Diagnostic Substances)